Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$966K Sell
35,000
-10,000
-22% -$221K 0.34% 104
2026
Q1
$658K Hold
45,000
0.3% 105
2025
Q4
$569K Hold
45,000
0.22% 114
2025
Q3
$692K Hold
45,000
0.25% 107
2025
Q2
$707K Hold
45,000
0.27% 104
2025
Q1
$860K Hold
45,000
0.35% 97
2024
Q4
$1.07M Hold
45,000
0.36% 92
2024
Q3
$1.26M Hold
45,000
0.43% 85
2024
Q2
$1.18M Hold
45,000
0.43% 81
2024
Q1
$984K Hold
45,000
0.31% 93
2023
Q4
$1.05M Hold
45,000
0.34% 105
2023
Q3
$888K Hold
45,000
0.3% 105
2023
Q2
$1.02M Hold
45,000
0.32% 95
2023
Q1
$884K Hold
45,000
0.28% 103
2022
Q4
$774K Buy
+45,000
New +$798K 0.22% 114

Other funds holding RXO

Formula Growth's RXO Position: Q2 2026 in Review

Formula Growth reduced its RXO (RXO) stake by 22% in Q2 2026, selling an estimated $221K and leaving 35,000 shares worth $966K. The position accounts for 0.34% of the portfolio, ranked #104.

Formula Growth first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.26M in Q3 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Formula Growth held 35,000 shares of RXO worth $966K as of Q2 2026.
  • Formula Growth sold 10,000 RXO shares in Q2 2026, an estimated $221K.
  • RXO made up 0.34% of Formula Growth's portfolio in Q2 2026, its #104 holding.
  • Formula Growth first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Formula Growth's RXO position peaked at $1.26M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.